Bessler Robert 4

What Happened
Robert Bessler, a director of LifeStance Health Group, sold a total of 75,000 shares on May 7, 2026 via open-market/private sale transactions. The reporting Form 4 shows a weighted average price of $8.55 per share for total proceeds of approximately $641,250. The sales were reported on Form 4 filed May 11, 2026.

Key Details

• Transaction date: 2026-05-07 (reported on Form 4 filed 2026-05-11; filing appears timely under Section 16 rules).
• Shares sold: 37,500 + 37,500 = 75,000 shares.
• Price: weighted average $8.55; filing notes individual trades ranged from $8.40 to $8.89. Reporting person can provide per-price breakdown on request (Footnote F1).
• Total proceeds: ~$641,250 ($320,625 per 37,500-share block).
• Shares owned after transaction: Not specified in this Form 4.
• Beneficial ownership notes: Footnotes F2–F4 state Bessler disclaims beneficial ownership except to the extent of his pecuniary interest; some shares were held of record by Alpine Glow Capital, of which he is manager and sole member.

Context
This was a sale (S) — common insider activity that can be for many reasons (diversification, tax planning, entity-level decisions). The filing is factual and does not indicate the insider’s motivation.